Projects

Informing VMMC provision in districts within countries in sub-Saharan Africa

Loveleen Bansi-Matharu (UCL)

Informing cost effective interventions to maximise continued engagement on ART in people with HIV 

Anna Bershteyn (NYU), Brooke Nichols (H²RO and BU)

Modelling the effects of structural interventions and social enablers on HIV incidence and mortality in sub-Saharan African countries (Series of papers)

Leigh Johnson (UCT)

Modelling to Inform HIV Programmes in sub-Saharan Africa (MIHPSA Collaboration)

Edward Kataika (East, Central and Southern Africa Health Community), Paul Revill (University of York), Andrew Phillips (UCL)

MIHPSA Malawi sub-project

Debra ten Brink (Burnet Institute), Rose Nyirenda (MOH Malawi), Carel Pretorius (Avenir Health)

MIHPSA South Africa sub-project

Leigh Johnson (UCT), Edinah Mudimu (University of South Africa), Thato Chidarikire (NDoH South Africa)

MIHPSA Zimbabwe sub-project

Valentina Cambiano (UCL), Isaac Taramusi (NAC Zimbabwe), Ngwarai Sithole (MoHCC, Zimbabwe)

The incremental benefit of Advanced HIV Disease (AHD) focussed interventions on AIDS mortality

Emily Hyle (MGH, Harvard), Kenneth Freedberg (MGH, Harvard)

Assessing the impact and utility of long acting PrEP to help control HIV epidemics in various risk population and settings

Marie-Claude Boily (Imperial College London), Dobromir Dimitrov (Fred Hutchinson Cancer Research Center)

Risk of INSTI resistance with use of Cab-LA long acting PrEP and implications for dolutegravir-based ART treatment

Jennifer Smith (UCL), Andrew Phillips (UCL) 

Oral HIV self tests expand PrEP access in sub-Saharan Africa

Katy Godfrey (Office of the Global AIDS Coordinator, Dept of State USA), Andrew Phillips (UCL)

Cost-effectiveness of easy-access risk-informed oral pre-exposure prophylaxis (PrEP) in HIV epidemics in sub-Saharan Africa

Andrew Phillips (UCL)

Attribution of HIV deaths to diagnosis and treatment status

Loveleen Bansi-Matharu (UCL), Anna Bershteyn (NYU)

Projecting TB and HIV incidence in Malawi under various potential programme enhancements

Tara Mangal (Imperial College London)

Opportunities to use HIV epidemic models to inform optimization of Global Fund primary HIV prevention portfolio investments for 2021-23 and 2024-26.

Identifying major sources of HIV transmission along the treatment and prevention continuum.